← Back to patent-cliff list
AG-1705
Tier C — Watch / tradeAG-1705
Ahn-Gook Pharmaceutical Co., Ltd.
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：AT1, Symporters, VDCCs
Indications (approved)：Cardiac and vascular disorders
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of AG-1705?
Approved indications include: Cardiac and vascular disorders.
When does the AG-1705 patent expire?
No public expiry year is available for AG-1705 yet; this page updates once verified.
How do I get a quote for AG-1705 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01